Pleased to lead the way, aiming at the global pharmaceutical market.
About TWi Pharmaceuticals USA, Inc.
TWi Pharmaceuticals USA Inc. is a wholly-owned subsidiary of TWi Pharmaceuticals Inc., a Taiwan-based specialty pharmaceutical company focusing on the development and commercialization of "High Barrier Generics" drugs, For more information about TWi Corporate and "High Barrier to Entry" generics, please click here to visit www.twipharma.com.
The TWi USA team is responsible for strategic decision making, business development and portfolio selection and oversight of all Sales and Marketing and Trade Relations activities in the United States.
Our goals are to establish a market presence in the United States, create sustainable profit with our high barrier generic drug pipeline and generate increased growth and value for our shareholders.
The key to TWi's success is based on 4 elements: Innovation, Integrity, Intelligence, and International. As a specialty pharmaceutical company, TWi thrives on overcoming technical challenges and innovations. At TWi, with our unique ability to integrate various kinds of expertise from R&D all the way to commercial production, we believe that it is our social responsibility to provide high quality and affordable generic and new drugs for patients worldwide.